Abberant Immunoglobulin G Glycosylation in Rheumatoid Arthritis by LTQ-ESI-MS

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2020 Mar 21

PMID 32192063

Citations 18

Authors

Zhipeng Su

Qing Xie

Yanping Wang

Yunsen Li

Affiliations

Soon will be listed here.

Abstract

Aberrant glycosylation has been observed in many autoimmune diseases. For example, aberrant glycosylation of immunoglobulin G (IgG) has been implicated in rheumatoid arthritis (RA) pathogenesis. The aim of this study is to investigate IgG glycosylation and whether there is an association with rheumatoid factor levels in the serum of RA patients. We detected permethylated -glycans of the IgG obtained in serum from 44 RA patients and 30 healthy controls using linear ion-trap electrospray ionization mass spectrometry (LTQ-ESI-MS), a highly sensitive and efficient approach in the detection and identification of N-glycans profiles. IgG N-glycosylation and rheumatoid factor levels were compared in healthy controls and RA patients. Our results suggested that total IgG purified from serum of RA patients shows significantly lower galactosylation ( = 0.0012), lower sialylation ( < 0.0001) and higher fucosylation ( = 0.0063) levels compared with healthy controls. We observed a positive correlation between aberrant N-glycosylation and rheumatoid factor level in the RA patients. In conclusion, we identified aberrant glycosylation of IgG in the serum of RA patients and its association with elevated levels of rheumatoid factor.

Citing Articles

Quantitative N-glycoproteomic analysis reveals glycosylation signatures of plasma immunoglobulin G in systemic sclerosis.

Cheng L, Li Y, Zhou Y, Ling Y, Wu T, Liang Z Front Immunol. 2025; 16:1531191.

PMID: 39991159 PMC: 11842340. DOI: 10.3389/fimmu.2025.1531191.

Glycosylation: mechanisms, biological functions and clinical implications.

He M, Zhou X, Wang X Signal Transduct Target Ther. 2024; 9(1):194.

PMID: 39098853 PMC: 11298558. DOI: 10.1038/s41392-024-01886-1.

Medical Relevance, State-of-the-Art and Perspectives of "Sweet Metacode" in Liquid Biopsy Approaches.

Pinkeova A, Kosutova N, Jane E, Lorencova L, Bertokova A, Bertok T Diagnostics (Basel). 2024; 14(7).

PMID: 38611626 PMC: 11011756. DOI: 10.3390/diagnostics14070713.

Reduced serum IgG galactosylation is associated with increased inflammation during relapses of neuromyelitis optica spectrum disorders.

Gao S, Jiao X, Guo R, Song X, Li B, Guo L Front Immunol. 2024; 15:1357475.

PMID: 38576616 PMC: 10991735. DOI: 10.3389/fimmu.2024.1357475.

Pharmacogenomics of intravenous immunoglobulin response in Kawasaki disease.

Shrestha S, Wiener H, Kajimoto H, Srinivasasainagendra V, Ledee D, Chowdhury S Front Immunol. 2024; 14:1287094.

PMID: 38259468 PMC: 10800400. DOI: 10.3389/fimmu.2023.1287094.

References

Bondt A, Rombouts Y, Selman M, Hensbergen P, Reiding K, Hazes J . Immunoglobulin G (IgG) Fab glycosylation analysis using a new mass spectrometric high-throughput profiling method reveals pregnancy-associated changes. Mol Cell Proteomics. 2014; 13(11):3029-39. PMC: 4223489. DOI: 10.1074/mcp.M114.039537. View

Pagan J, Kitaoka M, Anthony R . Engineered Sialylation of Pathogenic Antibodies In Vivo Attenuates Autoimmune Disease. Cell. 2017; 172(3):564-577.e13. PMC: 5849077. DOI: 10.1016/j.cell.2017.11.041. View

Ju L, Wang Y, Xie Q, Xu X, Li Y, Chen Z . Elevated level of serum glycoprotein bifucosylation and prognostic value in Chinese breast cancer. Glycobiology. 2015; 26(5):460-71. DOI: 10.1093/glycob/cwv117. View

Bondt A, Selman M, Deelder A, Hazes J, Willemsen S, Wuhrer M . Association between galactosylation of immunoglobulin G and improvement of rheumatoid arthritis during pregnancy is independent of sialylation. J Proteome Res. 2013; 12(10):4522-31. DOI: 10.1021/pr400589m. View

Arnold J, Wormald M, Sim R, Rudd P, Dwek R . The impact of glycosylation on the biological function and structure of human immunoglobulins. Annu Rev Immunol. 2006; 25:21-50. DOI: 10.1146/annurev.immunol.25.022106.141702. View

Matsumoto A, Shikata K, Takeuchi F, Kojima N, Mizuochi T . Autoantibody activity of IgG rheumatoid factor increases with decreasing levels of galactosylation and sialylation. J Biochem. 2000; 128(4):621-8. DOI: 10.1093/oxfordjournals.jbchem.a022794. View

Trbojevic Akmacic I, Ventham N, Theodoratou E, Vuckovic F, Kennedy N, Kristic J . Inflammatory bowel disease associates with proinflammatory potential of the immunoglobulin G glycome. Inflamm Bowel Dis. 2015; 21(6):1237-47. PMC: 4450892. DOI: 10.1097/MIB.0000000000000372. View

Ohmi Y, Ise W, Harazono A, Takakura D, Fukuyama H, Baba Y . Sialylation converts arthritogenic IgG into inhibitors of collagen-induced arthritis. Nat Commun. 2016; 7:11205. PMC: 4822049. DOI: 10.1038/ncomms11205. View

Kemna M, Plomp R, van Paassen P, Koeleman C, Jansen B, Damoiseaux J . Galactosylation and Sialylation Levels of IgG Predict Relapse in Patients With PR3-ANCA Associated Vasculitis. EBioMedicine. 2017; 17:108-118. PMC: 5360573. DOI: 10.1016/j.ebiom.2017.01.033. View

10.

Ciucanu I, Costello C . Elimination of oxidative degradation during the per-O-methylation of carbohydrates. J Am Chem Soc. 2003; 125(52):16213-9. DOI: 10.1021/ja035660t. View

11.

Bakovic M, Selman M, Hoffmann M, Rudan I, Campbell H, Deelder A . High-throughput IgG Fc N-glycosylation profiling by mass spectrometry of glycopeptides. J Proteome Res. 2013; 12(2):821-31. DOI: 10.1021/pr300887z. View

12.

Ferrara C, Grau S, Jager C, Sondermann P, Brunker P, Waldhauer I . Unique carbohydrate-carbohydrate interactions are required for high affinity binding between FcgammaRIII and antibodies lacking core fucose. Proc Natl Acad Sci U S A. 2011; 108(31):12669-74. PMC: 3150898. DOI: 10.1073/pnas.1108455108. View

13.

Iida S, Misaka H, Inoue M, Shibata M, Nakano R, Yamane-Ohnuki N . Nonfucosylated therapeutic IgG1 antibody can evade the inhibitory effect of serum immunoglobulin G on antibody-dependent cellular cytotoxicity through its high binding to FcgammaRIIIa. Clin Cancer Res. 2006; 12(9):2879-87. DOI: 10.1158/1078-0432.CCR-05-2619. View

14.

Watson M, Rudd P, Bland M, Dwek R, Axford J . Sugar printing rheumatic diseases: a potential method for disease differentiation using immunoglobulin G oligosaccharides. Arthritis Rheum. 1999; 42(8):1682-90. DOI: 10.1002/1529-0131(199908)42:8<1682::AID-ANR17>3.0.CO;2-X. View

15.

Hong Q, Ruhaak L, Stroble C, Parker E, Huang J, Maverakis E . A Method for Comprehensive Glycosite-Mapping and Direct Quantitation of Serum Glycoproteins. J Proteome Res. 2015; 14(12):5179-92. PMC: 4670571. DOI: 10.1021/acs.jproteome.5b00756. View

16.

Vidarsson G, Dekkers G, Rispens T . IgG subclasses and allotypes: from structure to effector functions. Front Immunol. 2014; 5:520. PMC: 4202688. DOI: 10.3389/fimmu.2014.00520. View

17.

Pucic M, Knezevic A, Vidic J, Adamczyk B, Novokmet M, Polasek O . High throughput isolation and glycosylation analysis of IgG-variability and heritability of the IgG glycome in three isolated human populations. Mol Cell Proteomics. 2011; 10(10):M111.010090. PMC: 3205872. DOI: 10.1074/mcp.M111.010090. View

18.

Rook G, Steele J, Brealey R, Whyte A, Isenberg D, Sumar N . Changes in IgG glycoform levels are associated with remission of arthritis during pregnancy. J Autoimmun. 1991; 4(5):779-94. DOI: 10.1016/0896-8411(91)90173-a. View

19.

Parekh R, Dwek R, Sutton B, Fernandes D, Leung A, Stanworth D . Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG. Nature. 1985; 316(6027):452-7. DOI: 10.1038/316452a0. View

20.

Ferrara C, Stuart F, Sondermann P, Brunker P, Umana P . The carbohydrate at FcgammaRIIIa Asn-162. An element required for high affinity binding to non-fucosylated IgG glycoforms. J Biol Chem. 2005; 281(8):5032-6. DOI: 10.1074/jbc.M510171200. View